Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C Beham-Schmid
The Derived Neutrophil to Lymphocyte Ratio Is an Independent Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma
British Journal of Cancer
Cancer Research
Oncology
High Expression of the Sister-Chromatid Separation Regulator and Proto-Oncogene hSecurin Occurs in a Subset of Myeloid Leukaemias but Is Not Implicated in the Pathogenesis of Aneuploidy
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Global Hypomethylation Is an Independent Prognostic Factor in Diffuse Large B Cell Lymphoma
American Journal of Hematology
Hematology
Prognostic Impact of Tumor-Associated Macrophages, Lymphocyte-To-Monocyte and Neutrophil-To-Lymphocyte Ratio in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients With Gastric Adenocarcinoma
Journal of Gastrointestinal Cancer
Oncology
Gastroenterology
Prognostic Performance of Lymphocyte-To-Monocyte Ratio in Diffuse Large B-Cell Lymphoma: An Updated Meta-Analysis of Eleven Reports
OncoTargets and Therapy
Oncology
Pharmacology
Blood Lymphocyte-To-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated With R-Chop
PLoS ONE
Multidisciplinary
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
Prognostic Significance of Peripheral Blood Absolute Lymphocyte Count and Derived Neutrophil to Lymphocyte Ratio in Patients With Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma
Cancer Management and Research
Oncology
miR‑150 Is a Negative Independent Prognostic Biomarker for Primary Gastrointestinal Diffuse Large B‑cell Lymphoma
Oncology Letters
Cancer Research
Oncology